Tilray Brands, Inc.

TSX:TLRY.TO

Drug Manufacturers - Specialty & Generic

Healthcare
$3.23 -1.19%

-$0.08 today

Market cap
$477.35M
Beta
1.88
P/E (TTM)
-0.3
EPS (TTM)
-$16.38
52W Low $0.49High $21.57

Volume 0.86M

Average 0.64M

TLRY.TO Sales of Investments

Cash received from selling or redeeming investments.

Tilray Brands, Inc.TSX: TLRY.TO

Sales of Investments · Q3 FY2026 · quarter ended Feb 2026

Sales of investments outflow grows to $21.1M

Q3 FY2026 sales of investments was $21.1M, compared with $0 a year earlier. Trailing-twelve-month sales of investments was $7.27M.

Context

  • Sales of investments amounted to 0.0% of revenue in FY2025, unchanged from a year earlier.
  • Sales of investments increased in 1 of the last 3 fiscal years.
  • FY2025 was the lowest annual figure in the 4 fiscal years shown.

What to watch

Whether quarterly sales of investments holds near $21.1M or moves back toward the trailing-twelve-month quarterly average of $1.82M.

Sources:Cash FlowText generated from reported figures; not investment advice.

Latest quarterFeb 2026
$21.1M+143.5% QoQ
Last fiscal yearMay 2025
$0— YoY
LTMFeb 2026
$7.27M-83.9% YoY
Sales of Investments past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter———
1 year———
3-year CAGR———
5-year CAGR——
10-year CAGR——

Sales of Investments history

USD · from the cash flow

Latest · FY2025
0 USD
Year-over-year change
—

Sales of Investments vs competitors

How TLRY.TO compares with its peers on the latest reported figures

  • Peers report in different currencies, so sales of investments is compared through growth and share of revenue rather than absolute size.
  • Its year-over-year change of -83.9% is the 2nd highest of 3, against a peer median of -65.1%.
  • Sales of investments amounts to 0.8% of revenue for TLRY.TO, versus a peer median of 1.0%.
TLRY.TO Competitors
Sales of Investments for TLRY.TO and competitors
Company Period LTM YoY 3-year CAGR% of revenue
SNDLSNDL Inc.LTM Mar 2026CA$18.79M CAD-30.2%—2.0%
TLRY.TOTilray Brands, Inc.LTM Feb 2026$7.27M USD-83.9%—0.8%
ACBAurora Cannabis Inc.LTM Mar 2026CA$0 CAD-100.0%—0.0%
GLASGlass House Brands Inc—— ———
Peer median (excluding TLRY.TO) —-65.1%—1.0%

Competitors are the stored peer set for TLRY.TO. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Cash Flow Statement

USD
Metric
FY2021
May 2021
FY2022
May 2022
FY2023
May 2023
FY2024
May 2024
FY2025
May 2025
Net Income(336.01M)(434.13M)(1.44B)(222.4M)(2.18B)
Depreciation & Amortization67.83M154.59M130.15M126.91M133.49M
Deferred Income Tax(24.87M)(27.54M)(31.95M)(38.87M)(121.02M)
Stock-Based Compensation17.35M35.99M39.6M31.77M24.29M
Change in Working Capital(50.94M)(91.77M)14.4M(8.87M)(62.56M)
Accounts Receivables(23.51M)(5.84M)4.17M(6.58M)(17.8M)
Inventory(35.29M)(45.75M)(12.93M)(15.58M)(13.56M)
Accounts Payables14.5M(44.65M)20.04M00
Other Working Capital(6.64M)4.47M3.14M(8.87M)(31.2M)
Other Non-Cash Items281.92M185.59M1.3B80.56M2.11B
Operating Cash Flow(44.72M)(177.26M)7.91M(30.91M)(94.6M)
Capital Expenditures(38.87M)(34.06M)(20.8M)(29.25M)(32.92M)
Acquisitions (Net)66.61M326K(26.72M)(52.12M)(18.11M)
Purchases of Investments6.61M0(241.9M)00
Sales of Investments8.43M0289.42M00
Other Investing Activities3.33M12.21M(285.11M)209.72M4.31M
Investing Cash Flow46.11M(21.53M)(285.11M)128.35M(46.72M)
Debt Repayment45.51M(123.55M)(58.25M)(83.81M)(26.14M)
Common Stock Issued102.55M262.51M129.59M8.62M161.19M
Common Stock Repurchased0(8.69M)(1.19M)00
Dividends Paid0(7.48M)000
Other Financing Activities(23.75M)0(804.41K)0(1.54M)
Financing Cash Flow124.31M128.2M70.16M(75.19M)133.51M
Effect of Forex Changes2.12M(1.96M)(2.23M)(549K)1.14M
Net Change in Cash127.82M(72.56M)(209.28M)21.71M(6.67M)
Free Cash Flow(83.59M)(211.33M)(12.89M)(60.15M)(127.52M)

Tilray Brands, Inc.

TSX:TLRY.TO

Intrinsic Alpha fair value

Locked

Current Price

$3.23

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.